Lightwave Logic, Inc.

What they do

Lightwave Logic develops and commercializes proprietary electro-optic (EO) polymer materials, marketed as the Perkinamine family, designed for integration into silicon photonics and other photonic integrated circuit platforms. The company does not manufacture transceivers, photonic devices, or optical modules; it monetizes through material sales, IP licensing, process design kit enablement, and royalty or fee-based arrangements tied to customer production. Customers and prospective customers are semiconductor foundries, silicon photonics designers, optical module manufacturers, and system integrators serving AI, cloud, data center, and telecommunications markets.

Revenue drivers

• Perkinamine material supply license — Commercial operations began May 2023 with a material supply license agreement to provide Perkinamine chromophore materials for polymer-based photonic devices and PICs; this is the only identified commercial arrangement and total annual revenue was $236,855 in 2025.
• Non-recurring engineering joint development — In 2025 the company entered a non-recurring engineering joint development arrangement with a customer to develop an electro-optical polymer-based modulator chip for communication applications.
• IP licensing, PDK enablement and royalties — The stated commercialization strategy also includes intellectual property licensing, process design kit enablement, and royalty or other fee-based arrangements tied to customer production, though no amounts are disclosed separately in the excerpts.

Recent performance

Annual revenue rose from $95,605 in 2024 to $236,855 in 2025, but the company remains pre-commercial at scale. Quarterly revenue was $29,166 in the quarter ended 2025-09-30, $159,167 in 2025-12-31, $29,167 in 2026-03-31, and $32,751 in 2026-06-30, showing a large spike in the December 2025 quarter. Net loss was $20.3 million in 2025 versus $22.5 million in 2024, and operating cash flow was negative $13.7 million in 2025 versus negative $15.6 million in 2024. At 2026-06-30, total assets were $108.1 million, total liabilities $3.9 million, shareholder equity $104.2 million, and cash and equivalents $47.2 million.

Strategy

Management's stated direction is to commercialize EO polymer technology through material sales, IP licensing, PDK enablement, and royalty or fee-based arrangements tied to customer production rather than manufacturing devices itself. The company runs a structured commercialization process covering evaluation, integration, qualification, and production readiness with foundries and photonics customers. Development priorities include material optimization for electro-optic efficiency, thermal stability, wavelength expansion, environmental robustness, and process integration. As of August 2026, management said multiple customer programs are progressing through defined development stages. The company continues to fund research and development and expects to incur operating losses through at least 2027.

Risks

• No history of profitability — The company reported net losses of $20,313,797 in 2025 and $22,535,041 in 2024, had an accumulated deficit of $167.3 million at December 31, 2025, and expects losses through at least 2027.
• Dependence on customer qualification cycles — Production revenue timing and scale depend on customer product qualification and adoption, technical validation, manufacturing readiness, and end-market demand, none of which the company controls.
• Minimal and lumpy revenue — Total 2025 revenue was only $236,855, and quarterly revenue swung from $159,167 in the 2025-12-31 quarter to $29,167 in the 2026-03-31 quarter.
• Restatement and disclosure events — An 8-K dated 2026-01-20 stated previously issued financials are not reliable, and other 8-K filings report officer or director changes, a terminated material agreement (2025-12-15), and newly entered material agreements (2026-04-21).

Outlook

Management states that multiple customer programs are progressing through defined development stages as of August 2026, but says the timing and scale of potential production revenue depend on customer qualification and adoption cycles, technical validation, manufacturing readiness, and end-market demand. The company anticipates continuing operating losses through at least 2027 and will need significant revenue to reach profitability. No revenue guidance or specific production commitments are provided in the excerpts.